Skip to main content
SpringerLink
Log in

The Effect of Combined Medical Treatment on Quality of Life in Persistent Allergic Rhinitis

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Allergic rhinitis may significantly affect the patients’ quality of life. The aim of this study was to compare the effects of nasal steroids alone, to nasal steroids plus Levocetirizine or Montelukast, on quality of life in persistent allergic rhinitis. This is a prospective, randomized study and included 56 patients with moderate to severe persistent allergic rhinitis. All patients had house dust mite allergy on skin prick test and we divided the patients into three groups. 1 month long medical treatment was; topical Mometasone furoate 200 mcg/day in the first group (n:14), Mometasone furoate 200 mcg/day plus oral Levocetirizine 5 mg/day in the second group (n:21), and Mometasone furoate 200 mcg/day plus oral Montelukast 10 mg/day in the third group (n:21). We evaluated the patients before treatment and at the first month after treatment with mini rhinoconjunctivitis quality of life questionnaire (miniRQLQ) and nasal symptom scores. In the first group nasal symptom and mini RQLQ scores were not improved but in second and third group, both scores were improved significantly (p < 0.05). Nasal obstruction symptom score was better in the third group after treatment (p < 0.01), but other nasal symptom scores (rhinorrhea, sneezing and nasal itching) were better in the second group (For each symptom p < 0.05). Improvement of quality of life scores in the second group were better than the third group (p < 0.05). In persistent allergic rhinitis, combination of levocetirizine or montelukast to nasal steroids was better than the topical mometasone furoate alone in terms of quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lundback B (1998) Epidemiology of rhinitis and asthma. Clin Exp Allergy 28(Suppl 2):3–10

    PubMed  Google Scholar 

  2. Bousquet J et al (2008) Allergic rhinitis and its impact on asthma(ARIA) 2008 update. Allergy 63(86):8–160

    Article  PubMed  Google Scholar 

  3. Pulleritis T, Praks L, Skoogh BE, Ani R, Lotvall J (1999) Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 159:1814–1818

    Article  Google Scholar 

  4. Weiner JM, Abramson MJ, Puy RM (1998) Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 317:1624–1629

    Article  PubMed  CAS  Google Scholar 

  5. Simons FE (2004) Advances in H1-antihistamines. N Engl J Med 351:2203–2217

    Article  PubMed  CAS  Google Scholar 

  6. Yanez A, Rodrigo GJ (2002) Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 89:479–484

    Article  PubMed  CAS  Google Scholar 

  7. Schenkel E (2003) Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis. Expert Opin Pharmacother 4:1579–1591

    Article  PubMed  CAS  Google Scholar 

  8. Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE et al (2004) Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 34:952–957

    Article  PubMed  CAS  Google Scholar 

  9. Berger WE, Nayak AS, Staudinger HW (2005) Mometasone furoate improves congestion in patients with moderatetor severe seasonal allergic rhinitis. Ann Pharmacother 39:1984–1989

    Article  PubMed  CAS  Google Scholar 

  10. Bhatia S, Baroody FM, de Tineo M, Naclerio RM (2005) Increased nasal airflow with budesonide compared with desloratadine during the allergy season. Arch Otolaryngol Head Neck Surg 131:223–228

    Article  PubMed  Google Scholar 

  11. Rosenblut A, Bardin PG, Muller B, Faris MA, Wu WW, Caldwell MF et al (2007) Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 62:1071–1077

    Article  PubMed  CAS  Google Scholar 

  12. Brannan MD, Herron JM, Reidenberg P, Affrime MB (1995) Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twicedaily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis. Clin Ther 17:637–647

    Article  PubMed  CAS  Google Scholar 

  13. Wilson AM, Sims EJ, McFarlane LC, Lipworth BJ (1998) Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis. J Allergy Clin Immunol 102:598–604

    Article  PubMed  CAS  Google Scholar 

  14. Kim KT, Rabinovitch N, Uryniak T, Simpson B, O’Dowd L, Casty F (2004) Effect of budesonide aqueous nasal spray on hypothalamic-pituitaryadrenal axis function in children with allergic rhinitis. Ann Allergy Asthma Immunol 93:61–67

    Article  PubMed  CAS  Google Scholar 

  15. Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C et al (2007) Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 62:1078–1084

    Article  PubMed  CAS  Google Scholar 

  16. Scadding GK (2004) Intranasal steroid sprays in the treatment of rhinitis is one better than another? J Laryngol Otol 118:395–396 author reply 6

    PubMed  CAS  Google Scholar 

  17. Blaiss MS, Benninger MS, Fromer L, Gross G, Mabry R, Mahr T et al (2006) Expanding choices in intranasal steroid therapy: summary of a roundtable meeting. Allergy Asthma Proc 27:254–264

    Article  PubMed  Google Scholar 

  18. Wilson AM, O’Byrne PM, Parameswaran K (2004) Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med 116:338–344

    Article  PubMed  CAS  Google Scholar 

  19. Rodrigo GJ, Yanez A (2006) The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol 96:779–786

    Article  PubMed  CAS  Google Scholar 

  20. Nathan RA, Yancey SW, Yancey SW, Waitkus-Edwards K, Prillaman BA, Stauer JL, Philpot E (2005) Fluticasone propionat nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 128:1910–1920

    Article  PubMed  CAS  Google Scholar 

  21. Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA et al (2006) Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Ann Allergy Asthma Immunol 96:851–857

    Article  PubMed  CAS  Google Scholar 

  22. Patel P, Philip G, Yang W, Call R, Horak F, LaForce C et al (2005) Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol 95:551–557

    Article  PubMed  Google Scholar 

  23. Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L et al (2007) Efficacy of montelukast for treating perennial allergic rhinitis. Allergy Asthma Proc 28:296–304

    Article  PubMed  CAS  Google Scholar 

  24. Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C (2004) Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in monotherapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 34:259–267

    Article  PubMed  Google Scholar 

  25. Saengpanich S, de Tineo M, Naclerio RM, Baroody FM (2003) Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg 129:557–562

    Article  PubMed  Google Scholar 

  26. Pullerits T, Praks L, Ristioja V, Lotvall J (2002) Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 109:949–955

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Ministry of Health, Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Dışkapı, Ankara, Turkey

    Emel Çadallı Tatar, Ünzile Akpınar Sürenoğlu, Ali Özdek & Güleser Saylam

  2. Department of Otolaryngology, Yıldırım Beyazıt University, Ankara, Turkey

    Hakan Korkmaz

Authors
  1. Emel Çadallı Tatar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ünzile Akpınar Sürenoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ali Özdek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Güleser Saylam
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hakan Korkmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emel Çadallı Tatar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tatar, E.Ç., Sürenoğlu, Ü.A., Özdek, A. et al. The Effect of Combined Medical Treatment on Quality of Life in Persistent Allergic Rhinitis. Indian J Otolaryngol Head Neck Surg 65 (Suppl 2), 333–337 (2013). https://doi.org/10.1007/s12070-012-0486-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-012-0486-9

Keywords

Search

Navigation